Enhancing the Development and Bringing to Market of
New Dermatological Therapeutic Options
Returning to Boston for the 4th year, Dermatology Drug Development Summit is the only industry-focused meeting dedicated to innovating, accelerating, and sharing pharmaceutical best practice on the development and bringing to market of new dermatological drugs, in the treatment of high unmet need.
Join this exclusive dermatology drug development community to network and learn from the leading experts in pharma, biotech and academia, to debate the end-to-end challenges in dermatology drug development: from discovering new research on key disease pathways, to unveiling critical preclinical insights, discussing formulation strategies, defining the optimal clinical development plans or evaluating commercialization approaches.
Navigate across 3 full days packed with dedicated, interactive formats to enhance the development and bringing to market of new dermatological therapeutic options, including a range of interactive workshops.
Discover how dermatology lends itself well to virtual clinical trials, the future of drug development in dermatology and the changing role of clinical and medical professionals during COVID-19.
The 2020 Speaker Faculty:
Global Senior Director, Medical, Immunology, Dermatology & Dupilumab
Vice President of Clinical Sciences, Inflammation & Immunology
Head of Global Market Access, Health Economics, Reimbursement & Pricing